Detailed Information

Cited 15 time in webofscience Cited 15 time in scopus
Metadata Downloads

The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Reportopen access

Authors
Han, Sang AhPark, Sue K.Ahn, Sei-HyunSon, Byung HoLee, Min HyukChoi, Doo HoNoh, Dong-YoungHan, WonshikLee, Eun SookHan, Seo KyungKim, Lee SuJung, YongsikKim, Ku SangSuh, Young JinMoon, Byung-InNam, Seok-JinNoh, Woo-ChulLee, Jeong EonKim, Sung-Won
Issue Date
Jun-2009
Publisher
KOREAN BREAST CANCER SOC
Keywords
Breast neoplasms; Ovarian neoplasms; Penetrance of BRCA mutation; Risk
Citation
JOURNAL OF BREAST CANCER, v.12, no.2, pp 92 - 99
Pages
8
Indexed
SCIE
SCOPUS
KCICANDI
Journal Title
JOURNAL OF BREAST CANCER
Volume
12
Number
2
Start Page
92
End Page
99
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/35574
DOI
10.4048/jbc.2009.12.2.92
ISSN
1738-6756
2092-9900
Abstract
Purpose: To estimate the cumulative risk till each age (penetrance) of breast and ovarian cancers among female family members with BRCA1 and BRCA2 mutation. Methods: Among the 61 BRCA1 mutation carriers in the 42 families and 47 BRCA2 mutation carriers in 31 families identified at 5 academic breast clinics, the probands were excluded to estimate the cumulative risk till each age of breast cancer in the Korean BRCA1 and BRCA2 carriers. Using Kaplan-Meier analyses, cumulative cancer risk estimates were determined. Results: By the age 70, the female breast cancer risk for the BRCA1 and BRCA2 mutation carriers was 72.1% (95% confidence interval [CI]=59.5% to 84.8%) and 66.3% (95% CI=41.2% to 91.5%), respectively, and the ovarian cancer risk was 24.6% (95% CI=0% to 50.3%) and 11.1% (95% CI=0% to 31.6%), respectively. The contralateral breast cancer risk at 5 years after primary breast cancer was estimated as 16.2% (95% CI=9.3% to 23.1%) for the 52 breast cancer patients with the BRCA1 mutation and 17.3% (95% CI=9.7% to 24.0%) for the 35 breast cancer patients with the BRCA2 mutation. Conclusion: The penetrance of BRCA mutations in Korea is largely consistent with the previous studies on Western populations. However, the small number of the cases, the high proportions of probands in the study subjects, the short term follow-up, and large confidence intervals are the limitations of the current study. The Korean Hereditary Breast Cancer Study (KOHBRA Study) may definitely answer this question.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Surgery > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE